Not shorting shares at all but interested in accountability. Having some background in statistics I am always aware that ANOVA and similar statistics have fundamental grounding. Removal of subjects as in all statistics can result in problems with outcomes as well as validity, not to mention reliability. One would hope that the next stage has good outcomes without much room to cavil. After all, medicine is a field which requires a vital attention to detail and human life is always the concern.
News 
Market Data 
Discover 
